Empower Pharmacy FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Nov 14, 2025
  • Last warning letter 2026
Inspections 8 7 OAI
Recalls 4 0 Class I (0%)
Warning letters 5 Latest Sep 18, 2026
510(k) clearances 0 None on file

Empower Pharmacy has 4 FDA recalls, 8 inspections, 0 510(k) clearances and 5 compliance actions on record. FDA has issued 5 warning letters to Empower Pharmacy, the most recent on Sep 18, 2026. FDA has published 7 Form 483s for Empower Pharmacy.

What these totals cover: FDA records filed under the name "Empower Pharmacy" and its spelling variants "Empower Clinic Services", "Empower Clinic Services Llc Dba Empower Pharmacy", "Empower Clinic Services, Llc Dba Empower Pharmacy".

Latest recall
D-0420-2025 · Class II · May 2, 2025
Latest inspection
Nov 14, 2025 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls4Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections8Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions5Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Empower Pharmacy's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Empower Pharmacy: FDA inspections per year

2017: 0 inspections (0 OAI), 1 warning letter, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 1 warning letter, 0 recall records (0 Class I) 2022: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (1 OAI), 0 warning letters, 1 recall record (0 Class I) 2024: 2 inspections (2 OAI), 0 warning letters, 2 recall records (0 Class I) 2025: 1 inspection (1 OAI), 2 warning letters, 1 recall record (0 Class I) 2026: 0 inspections (0 OAI), 1 warning letter, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600100
202511210
202422020
202311010
202211000
202100100
202011000
201900000
201810000
201700100

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Empower Pharmacy as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Empower Pharmacy yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Empower Pharmacy FDA Warning Letters

5 warning letters from May 25, 2017 to Sep 18, 2026.

IssuedSubjectIssuing officeClose-out letter
Sep 18, 2026 · Letter on fda.gov CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New DrugCenter for Drug Evaluation and Research (CDER)
Apr 2, 2025 · Record page
Apr 2, 2025 · Letter on fda.gov Compounding Pharmacy/Adulterated Drug ProductsCenter for Drug Evaluation and Research (CDER)
Oct 15, 2021 · Letter on fda.gov Compounding Pharmacy/Adulterated Drug ProductsOffice of Pharmaceutical Quality Operations, Division II
May 25, 2017 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Empower Pharmacy Form 483s

7 Form 483s published by FDA.

DateDocumentFEI
Nov 15, 2025 · Document on fda.gov 4833021758709
Oct 4, 2024 · Document on fda.gov 4833021758709
Aug 28, 2024 · Document on fda.gov 4833011887629
Aug 6, 2022 · Document on fda.gov 4833011887629
Mar 6, 2020 · Document on fda.gov 4833011887629
Oct 24, 2018 · Document on fda.gov 4833011887629
Aug 22, 2016 · Document on fda.gov 4833011887629

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

4 recall records from May 12, 2023 to May 2, 2025.

NumberClassProductDate
D-0420-2025Class IITestosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multiple-Dose Vial…May 2, 2025
D-0663-2024Class IIPyridoxine HCL (B6) Injection Solution, 100mg/mL, 30 mL Sterile Multiple-Dose Vial, For IM or IV use…Sep 5, 2024
D-0630-2024Class IIEmpower Pharmacy, Estradiol Cypionate Injection, 10mg/mL, 5mL Sterile Multiple Dose Vial, For IM or…Aug 2, 2024
D-0865-2023Class IIASCORBIC ACID PRESERVED INJECTION SOLUTION, 500 mg/mL, 30 mL Sterile Multiple-Dose Vial, RX ONLY…May 12, 2023

Recent FDA inspections

8 inspections from Nov 25, 2015 to Nov 14, 2025.

DateSiteProductClassificationFEI
Nov 14, 2025Houston, TXDrugsOfficial Action Indicated (OAI)3021758709
Oct 4, 2024Houston, TXDrugsOfficial Action Indicated (OAI)3021758709
Aug 28, 2024Houston, TXDrugsOfficial Action Indicated (OAI)3011887629
Dec 1, 2023Houston, TXDrugsOfficial Action Indicated (OAI)3021758709
Aug 5, 2022Houston, TXDrugsOfficial Action Indicated (OAI)3011887629
Mar 6, 2020Houston, TXDrugsOfficial Action Indicated (OAI)3011887629
Jan 24, 2018Houston, TXDrugsVoluntary Action Indicated (VAI)3011887629
Nov 25, 2015Houston, TXDrugsOfficial Action Indicated (OAI)3011887629
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 5 compliance actions under Empower Pharmacy: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Sep 18, 2026.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3021758709Houston, TX3Nov 14, 2025
FEI 3011887629Houston, TX5Aug 28, 2024

Empower Pharmacy and the FDA: common questions

Has Empower Pharmacy received an FDA warning letter?

Yes. FDA has issued 5 warning letters to Empower Pharmacy. The most recent is dated Sep 18, 2026, with the subject "CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug".

Has Empower Pharmacy received an FDA Form 483?

FDA has published 7 Form 483s for Empower Pharmacy in its reading room, the most recent dated Nov 15, 2025. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Empower Pharmacy?

The most recent FDA inspection on file ended Nov 14, 2025 at Houston, TX and was classified OAI. FDA has 8 inspections of Empower Pharmacy on file, 7 of them classified OAI (official action indicated).

Has Empower Pharmacy had an FDA recall?

Yes. Empower Pharmacy has 4 FDA recalls on record. The most recent started May 2, 2025.

Need more than this page shows? Ask about Empower Pharmacy in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.